Navigation Links
Vyta Corp Announces Engagement of Dr. Nino Sorgente as Independent Consultant
Date:10/8/2008

DENVER, Oct. 8 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that effective October 7, 2008, Dr. Nino Sorgente has been formally engaged as an independent scientific consultant to Vyta Corp. Dr. Sorgente was formerly Vice President of Research and Development at BIOAGRA, LLC, a joint venture, equally owned by Vyta Corp and Justin Holdings, Inc. On September 15, 2008, Vyta Corp announced its filing of foreclosure litigation against BIOAGRA, LLC. BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement.

"We are pleased to retain the services of Dr. Sorgente," said Paul H. Metzinger, President and CEO of Vyta Corp. "Dr. Sorgente is recognized as one of the leading Beta glucan researchers for his contributions to the cosmetic, medical and agricultural applications of Beta glucan."

About Vyta Corp

Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC:VYTA).

In addition to its interest in BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .

About BIOAGRA, LLC

BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), which is a purified, all natural, nontoxic yeast Beta 1,3/1,6-D-glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.

This announcement contains forward-looking statements about Vyta Corp that may involve risks and uncertainties. Important factors relating to the Company's operations could cause results to differ materially from those in forward-looking statements and further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC website (http://www.sec.gov). All forward-looking statements are based on information available to Vyta Corp on the date hereof and Vyta Corp assumes no obligation to update such statements.

Contacts:

Vyta Corp

Paul H. Metzinger

President & Chief Executive Officer

370 17th St.

Suite 3640

Denver, CO 80202

303-592-1010

Fax: 303-592-1054

E-mail: paul@vytacorp.com


'/>"/>
SOURCE Vyta Corp
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Disaboom Announces Preliminary Third Quarter Results
2. Medifast Announces Opening of First Franchise Clinic
3. SXC Health Solutions announces PBM certification from the HR Policy Association
4. ALL Care Dental Plan Announces Expansion to New Key States
5. ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly
6. Alfred Taubman Announces New $22M Gift to U-M
7. Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix
8. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
9. Vision Audio Inc. Announces New EASe Games Designed for Children with Autism
10. Information Management Solutions Provider OCI Announces Redesign of Corporate Web Site
11. Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... ... for qualifying into the Senior International Elite division on February 12th. Ms. ... Around divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Department of Justice jointly issued a letter to withdraw previous guidance ... with their gender identity. The guidance issued in May 2016 by the Obama ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, ... be participating in Rare Disease Day events, hosted by the Rare Disease Legislative ... Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews with ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Hamlin Dental ... announce that they are sponsoring a raffle. Throughout the month of February, patients who ... receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... “Doping in Sport: How the Culture Might Change,” in conjunction with ... symposium will be held at Pepperdine University in Malibu, California. , Sir Philip ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Following receiving CE Marking in Europe ... AMAR is a major milestone for the country where the device was developed ... market in Israel   ... inclusion in the National Health Basket , Israel , ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced wound ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Global Empty Capsules Market is poised to grow at a ... billion by 2025. This industry report analyzes the market ... as regional levels presented in the research scope. The study provides historical ...
(Date:2/24/2017)... , Feb. 24, 2017 Physician General ... Drug and Alcohol Programs Jennifer Smith commended ... providing training for and using naloxone, a life-saving overdose ... McCullough , a recovery specialist and overdose survivor who ... EMS providers. "A significant part of fighting ...
Breaking Medicine Technology: